Using Lab 2.0 to Combat Opioid-use Disorder: Lessons Learned and What Comes Next in Improving Patient Outcomes and Cost of Care

Dark Daily Webinar – Wednesday, June 12  at 1 PM EDT

Order DVD Now

Opioid overuse and addiction continue to contribute significantly to health issues of the nation’s population and to the increased cost of healthcare, making it even more vital for providers to optimally prescribe for and monitor, in the safest manner, their patients using opioid drugs.

The role of clinical laboratories in developing improvements within the continuum of care for this national health crisis is key. The lab can serve a facilitative and collaborative role by helping providers better understand drug test ordering and correct interpretation, and can add tangible value by simplifying and automating delivery of straightforward and actionable information to providers.

In this role, and to most efficiently assist doctors, pharmacists, and providers tackle the opioid crisis—it is imperative that clinical labs integrate Lab 2.0 measures in order to implement responsible, effective, outcomes-based treatment plans. Clinical Lab 2.0 is the path that is urgent for labs to follow, in order to deliver results for both patients and providers as the challenge of managing opioid use is confronted.

This 90-minute webinar, including an interactive Q&A session, will describe the valuable skills and techniques your lab needs to move beyond Lab 1.0, and to identify and implement measures for new, Clinical Lab 2.0 value-based interventions. You’ll hear a case study of one institution where a clinical need emerged regarding chronic pain management, and how their lab partnered with primary care, psychiatry, pharmacy, and others both within and outside the organization, to improve patient care, provider confidence, and overall cost of care.

Order DVD Now


Attend this program,
 and you will learn to:

  • Define the basic principles of Clinical Lab 2.0 and its role in patient outcomes and cost of care
  • Understand the critical success factors for delivering more value with lab testing services and your Lab 2.0 project
  • Identify value-based interventions your facility can design using laboratory data to improve delivery of information to providers, and improve patient care for opioid-use disorder
  • Recognize and reach key stakeholders and decision-makers to communicate the added value of your project and facilitate its success
  • Develop a project roadmap, identify milestone achievements, and learn the use of results metrics to document added value
  • Measure the clinical and fiscal outcomes of a Clinical Lab 2.0 project
  • Use the skills you’ll gain to generate the reimbursement necessary to maintain clinical excellence and financial stability for your lab

Who should attend?

  • Hospital Administrators and Department Heads
  • Laboratory Directors, Managers, and Supervisors
  • Other laboratory decision-makers and decision-influencers

Your registration includes:

  •  A site license to attend the webinar. Invite as many members of your team as you would like!
  • A full transcript emailed to you soon after the conference
  • The opportunity to pose specific questions, and connect directly with the speakers during the audience Q&A session

Order DVD Now

 

Our experts:

Bernard C. Cook, PhD, DABCC, FACB
Division Head, Chemistry
Director, Automated Core Laboratory Operations
Henry Ford Hospital
Detroit, MI

Monique Dodd, Pharm D., PhC., MLS(ASCP)
Enterprise Clinical Solutions Specialist
TriCore Reference Laboratories
Albuquerque, NM

 


THE DARK REPORT WEBINAR AT A GLANCE

DATE:                       Held Wednesday, June 12th
TIME:                        1 PM EDT; Noon CDT; 10 AM PDT
PLACE:                     Your computer and/or speakerphone
COST:                        $195 per site 
TO ORDER:         Click here or call 512-264-7103


Speakers:

Bernard C. Cook, PhD, DABCC, FACB

Bernard C. Cook, PhD, DABCC, FACB
Division Head, Chemistry
Director, Automated Core Laboratory Operations
Henry Ford Hospital
Detroit, MI

Dr. Bernard C. Cook is Division Head of Chemistry and Director of Operations of the core automated laboratory at Henry Ford Hospital in Detroit. He previously worked at Holsten Valley Medical Center, Marquette University, and Beckman Coulter, and has served in leadership positions with AACC, CLSI, and NACB. Dr. Cook has presented at United States and international congresses and has published his research in laboratory medicine and medical journals. He earned his PhD in pathology at the Medical College of Wisconsin, and trained in clinical chemistry at Washington University School of Medicine.

Monique Dodd, Pharm D., PhC., MLS(ASCP)CM

Monique Dodd, Pharm D., PhC., MLS(ASCP)
Enterprise Clinical Solutions Specialist
TriCore Reference Laboratories
Albuquerque, NM

Dr. Monique Dodd has been working as a pharmacist clinician at TriCore Reference Laboratories since July 2016. As Manager of Enterprise Clinical Solutions for the Diagnostic Optimization team, her primary focus is designing laboratory driven targeted interventions to optimize screening, diagnosis, monitoring and treatment of high-cost, high-risk, and high-frequency health conditions. Her areas of focus are infectious diseases, chronic pain management, and anticoagulation. Dr. Dodd has a unique education background that brings laboratory diagnostics and pharmacy together. She earned her BS in medical laboratory sciences from UNM Health Sciences Center in 2007. She was hired at TriCore as a medical technologist and worked for the infectious disease research and development team for three years. She was then accepted to the UNM College of Pharmacy program in 2010, where she interned in the therapeutics research infectious disease lab. Upon graduation, she entered into a collaborative postgraduate, year-one residency with TriCore and the UNM COP, with a focus in clinical pharmacy and laboratory diagnostics. Through this partnership, Dr. Dodd continued her training and earned her pharmacist clinician license while completing a pharmacy fellowship in 2016.